Cytokinetics (CYTK) Other financing activities (2010 - 2026)
Cytokinetics (CYTK) posted quarterly Other financing activities of $11.3 million for Q1 2026, up 48.29% year-over-year from $7.7 million in Q1 2025, and down 22.54% quarter-over-quarter from $14.6 million in Q4 2025.
Cytokinetics (CYTK) Other financing activities (2010 - 2026) Analysis & Trends
Cytokinetics (CYTK) has reported Other financing activities for 12 consecutive years, with $11.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 48.29% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $39.7 million (up 27.43% YoY), while the FY2025 annual figure was $36.0 million, down 32.14% from the prior year.
- Other financing activities retreated to $11.3 million in Q1 2026 per CYTK's latest filing, from $14.6 million in the prior quarter.
- Across five years, Other financing activities topped out at $29.5 million in Q1 2024 and bottomed at -$12.4 million in Q4 2023.
- Historically, Other financing activities has averaged $6.9 million across 5 years, with a median of $6.3 million in 2024.
- Annual changes were most pronounced in 2023 — Other financing activities slumped 443.47% — and 2024, when it jumped 732.59%.
- Cytokinetics' Other financing activities stood at $3.6 million in 2022, then plunged by 443.47% to -$12.4 million in 2023, then jumped by 152.44% to $6.5 million in 2024, then jumped by 126.05% to $14.6 million in 2025, then fell by 22.54% to $11.3 million in 2026.
- Business Quant data shows CYTK's Other financing activities at $11.3 million in Q1 2026, $14.6 million in Q4 2025, and $21.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Cytokinetics | 10.31 Bn | 9.14 Bn | 25.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 38.00 Mn |
| Jun 30, 2026 | 38.00 Mn |
| Mar 31, 2026 | 11.35 Mn |
| Mar 31, 2026 | 11.35 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Dec 31, 2025 | 14.65 Mn |
| Sep 30, 2025 | 21.33 Mn |
| Sep 30, 2025 | 21.33 Mn |
| Jun 30, 2025 | -7.65 Mn |
| Jun 30, 2025 | -7.65 Mn |
| Mar 31, 2025 | 7.65 Mn |
| Mar 31, 2025 | 7.65 Mn |
| Dec 31, 2024 | 6.48 Mn |
| Dec 31, 2024 | 6.48 Mn |
| Sep 30, 2024 | 6.32 Mn |
| Sep 30, 2024 | 6.32 Mn |
| Jun 30, 2024 | 10.69 Mn |
| Jun 30, 2024 | 10.69 Mn |
| Mar 31, 2024 | 29.53 Mn |
| Mar 31, 2024 | 29.53 Mn |